Aldeyra Therapeutics Schedules Webcast and Convention Name to Report Third-Quarter 2021 Monetary Outcomes and Talk about Latest Enterprise Highlights

LEXINGTON, Mass., October 21, 2021–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host a convention name at 8:00 a.m. ET Thursday, October 28, 2021 to report monetary outcomes for the quarter ended September 30, 2021 and talk about latest enterprise highlights.

The dial-in numbers are (866) 211-4098 for home callers and (647) 689-6613 for worldwide callers. The Convention ID quantity is 8891298. A reside webcast of the convention name will even be obtainable on the Traders & Media web page of the corporate’s company web site at

After the reside webcast, the occasion will stay archived on the Aldeyra Therapeutics web site for 90 days.

About Aldeyra Therapeutics, Inc.

Aldeyra Therapeutics is a biotechnology firm growing novel immune-modulating therapies to deal with ocular and systemic illnesses. Two of the corporate’s lead product candidates, reproxalap and ADX-629, goal RASP, that are pre-cytokine, systems-based mediators of irritation. Reproxalap is being evaluated in Section 3 scientific trials in sufferers with dry eye illness and allergic conjunctivitis. The corporate’s scientific pipeline additionally consists of ADX-2191 (methotrexate for intravitreal injection), a drug candidate in Section 3 testing for the prevention of proliferative vitreoretinopathy. For extra data, go to and comply with us on LinkedIn, Fb, and Twitter.

View supply model on


Company Contact:
Joshua Reed
Aldeyra Therapeutics, Inc.
Tel: 781-761-4904 ext. 218
[email protected]

Investor & Media Contact:
Scott Solomon
Sharon Merrill Associates, Inc.
Tel: 617-542-5300
[email protected]

Related posts